Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the Multiple Myeloma Test By FISH is typically 7-10 business days. However, this timeframe may vary depending on the specific laboratory and testing facility.

What are the prerequisites for the test Multiple Myeloma Test By FISH

  • Age: 18 years and above
  • Patients with suspected or diagnosed multiple myeloma
  • Patients with abnormal protein levels in blood or urine
  • Patients with unexplained bone pain or fractures
  • Patients with anemia, kidney dysfunction, or hypercalcemia
  • Patient consent for the test

What are the measure values for the test Multiple Myeloma Test By FISH

  • Normal: Less than 5% of cells with abnormal FISH results
  • Borderline: 5-10% of cells with abnormal FISH results
  • Abnormal: More than 10% of cells with abnormal FISH results

What does this test Multiple Myeloma Test By FISH identify?

Multiple Myeloma Test By FISH

This test, also known as Fluorescence In Situ Hybridization (FISH) test, is used to identify abnormalities in the chromosomes of plasma cells. Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell responsible for producing antibodies. In this test, a fluorescently labeled probe is used to detect specific genetic abnormalities, such as translocations or deletions, in the chromosomes of the plasma cells. These abnormalities can help in diagnosing multiple myeloma and determining the prognosis of the disease.

Why is this test Multiple Myeloma Test By FISH taken?

Multiple Myeloma Test By FISH is taken to detect abnormalities in chromosomes that are associated with multiple myeloma, a type of blood cancer. Fluorescence in situ hybridization (FISH) is a laboratory technique used to detect specific DNA sequences in chromosomes. In the case of multiple myeloma, FISH can identify genetic changes, such as translocations or deletions, that are characteristic of the disease.

Popular FAQs on Test

A Multiple Myeloma Test by FISH is a diagnostic test that uses fluorescence in situ hybridization (FISH) to detect genetic abnormalities in plasma cells, which can help diagnose multiple myeloma and guide treatment decisions.
During the test, a sample of bone marrow or blood is collected and analyzed using FISH technology to look for specific genetic changes associated with multiple myeloma.
The test can detect abnormalities such as translocations involving the immunoglobulin heavy chain (IgH) gene on chromosome 14, deletions of chromosome 13, and other changes that are commonly found in multiple myeloma patients.
The test is important because it can provide valuable information about the genetic characteristics of a patient's multiple myeloma, which can help determine prognosis, guide treatment decisions, and monitor response to therapy.
The test is minimally invasive and typically involves a bone marrow biopsy or blood draw, which are routine procedures that are well tolerated by most patients.

Customer Google Rating